ADAGIO MEDICAL HOLDINGS, INC. Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent
ADAGIO MEDICAL HOLDINGS, INC. (ADGM) reported Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent of -0.90% for the 5-month period ending 2024-12-31, per its 10-K filed 2026-03-27.
Financial Statements › Expense Statement › Income Tax
us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpense · last filed 2026-03-27
- ADAGIO MEDICAL HOLDINGS, INC. effective income tax rate reconciliation, nondeductible expense, percent for fiscal 2023 was -1.20%.
| Period end | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent 5 month | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent 12 month |
|---|---|---|
| 2024-12-31 | -0.90% 10-K · filed 2026-03-27 | |
| 2023-12-31 | -1.20% 10-K · filed 2025-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |
| Catheter Precision, Inc. (VTAK) | United States | $0.002B | -0.23 |